Pompe Disease Therapeutic Market Global Industry Insights, Analysis, Trends and Forecast, 2017-2025
Increasing government initiatives is expected to augment growth of the pompe disease therapeutic market
Increasing government initiatives is expected to augment growth of the pompe disease therapeutic market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REPORT DESCRIPTION<br />
<strong>Pompe</strong> <strong>Disease</strong> <strong>Therapeutic</strong> <strong>Market</strong>: Key Players<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
Amicus <strong>Therapeutic</strong>s, Inc.<br />
Valerion <strong>Therapeutic</strong>s.<br />
LLC.<br />
Sanofi S.A.<br />
Oxyrane.<br />
Sangamo <strong>Therapeutic</strong>s, Inc.<br />
The high cost associated with the treatment <strong>and</strong> long duration of the treatment are the factors restraining growth of<br />
the pompe disease therapeutic market. For instance, according to a research paper published by Harvard School, in<br />
2016, Lumizyme accounted for US$ 100,000 per year for children <strong>and</strong> US$ 300,000 per year for adult treatments.<br />
Complete Report Details @<br />
https://www.coherentmarketinsights.com/ongoing-insight/pompe-disease-therapeutic-market-1316<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
Change language